Study finds predictors of Poor Renal Outcome in Emphysematous Pyelonephritis

Written By :  Aashi verma
Published On 2026-03-29 14:45 GMT   |   Update On 2026-03-29 14:46 GMT

Emphysematous pyelonephritis (EPN) is a severe renal infection with a high risk of kidney function deterioration. Researchers have found in a new study that renal parenchymal involvement of more than 50% on initial imaging was the strongest independent predictor of poor outcomes in emphysematous pyelonephritis. Other contributing factors included high blood sugar levels (RBS >200 mg/dL), advanced disease (Huang-Tseng Class 3b), and persistent gas in the kidney on follow-up. Early recognition of these clinical and imaging predictors can aid in risk stratification and guide management to preserve renal function.

These findings are published in Therapeutic Advances in Urology in February 2026.

While historical research on emphysematous pyelonephritis (EPN) has primarily focused on immediate mortality and the necessity of total organ removal, a critical clinical gap exists regarding the factors that influence long-term renal outcomes in survivors, prompting Anupam Choudhary and colleagues from the Department of Urology at Kasturba Medical College to conduct a study aimed at identifying predictors for the development of poorly functioning kidneys (PFK).

The retrospective observational study evaluated 151 adults at a university teaching hospital over a five-year period, utilizing non-contrast computed tomography (NCCT) for staging and radionuclide renography at least four weeks post-presentation to assess the primary endpoint of differential function; patients with pre-existing chronic kidney disease (CKD) or those requiring immediate emergency nephrectomy were excluded to maintain a focus on functional recovery in preserved organs

Key Clinical Findings of the Study Include:.

  • Dominant Predictive Marker: The investigation demonstrated that renal parenchymal involvement of more than 50% on initial imaging was the only independent and most significant predictor of poor long-term function, carrying an adjusted odds ratio of 648.2.

  • Glycemic Control Influence: In the study, the higher metabolic distress at admission, defined as random blood sugar (RBS) levels exceeding 200 mg/dL, was significantly associated with the failure of the kidney to recover its normal function.

  • Impact of Radiological Stage: The study shows that the severe disease classifications, specifically Huang-Tseng Class 3b which indicates extensive infection spread, were found to have a strong statistical correlation with the development of poorly functioning kidneys compared to lower-grade infections.

  • Persistence of Infection: The research identified that the continued presence of gas within the renal parenchyma on follow-up imaging sessions served as a reliable indicator of non-viable tissue and irreversible structural injury.

The results suggest that EPN is a fulminant infection where specific radiological and clinical indicators, particularly tissue destruction exceeding 50%, can predict significant renal functional decline in 15.2% of cases.

Thus, the study concludes that practitioners may consider utilizing these clinical and radiological predictors to support early risk stratification and guide individualized management strategies aimed at preserving renal function.

Although the single-center retrospective design and the exclusion of immediate surgical cases may limit the broad application of these findings, there is a clear need for future multi-center prospective research to enhance the accuracy of these predictive models and refine patient counseling protocols.

Reference

Choudhary A, Gali KV, Surag KR, et al. Predictors of poor kidney function in patients with emphysematous pyelonephritis: a retrospective observational study. Ther Adv Urol. 2026;18:1-10.




Tags:    
Article Source : Therapeutic Advances in Urology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News